{
    "hands_on_practices": [
        {
            "introduction": "The initial evaluation of a child with a first-time febrile seizure hinges on accurate risk stratification. While the criteria for a simple febrile seizure are well-defined, their application is not universal across all age groups. This problem  challenges you to apply fundamental pediatric principles to a high-risk scenario—a seizure in an infant under six months—where the differential diagnosis must prioritize life-threatening infections over a benign febrile seizure.",
            "id": "5143498",
            "problem": "A $4$-month-old previously healthy infant is brought to the emergency department after a single episode of generalized tonic stiffening followed by rhythmic jerking of all extremities lasting approximately $3$ minutes. The episode self-terminated. The parent reports fever for $8$ hours with a maximum temperature at home of $39.1\\,^{\\circ}\\mathrm{C}$. There is no history of prior seizures, no sick contacts with known central nervous system infections, and no recent antibiotic exposure. Immunizations are up to date for age (completed the $2$-month and $4$-month series, including two doses of Haemophilus influenzae type b (Hib), which does not complete the full primary Hib series). On arrival, the infant is somnolent for approximately $10$ minutes and then returns to baseline, interactive and feeding. Vital signs show temperature $38.7\\,^{\\circ}\\mathrm{C}$, heart rate $160$ beats per minute, respiratory rate $36$ breaths per minute, and blood pressure $82/48\\,\\mathrm{mmHg}$. Examination shows a soft, non-bulging anterior fontanelle, no nuchal rigidity, normal tone and strength, symmetric reflexes, and no focal neurologic deficits. There are no signs of trauma or rash.\n\nUsing fundamental definitions and well-tested clinical facts about febrile seizures and infant physiology, determine the most appropriate evaluation strategy for this infant and justify why classic simple febrile seizure criteria are not met. Your choice should also reflect key alternative diagnoses that must be considered in this age group and the appropriate urgency and sequencing of tests.\n\nWhich option is the best next step?\n\nA. Reassure and discharge after observation; diagnose a simple febrile seizure because the convulsion was generalized, lasted less than $15$ minutes, and occurred once in $24$ hours. No laboratory tests, no lumbar puncture (LP), and no antimicrobials are needed.\n\nB. Recognize that age less than $6$ months excludes a classic simple febrile seizure diagnosis; perform urgent LP with cerebrospinal fluid (CSF) cell count, glucose, protein, Gram stain, and culture, and add Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) if encephalitis is a concern; obtain serum glucose, sodium, and calcium, a complete blood count and blood culture, urinalysis and urine culture; initiate empiric intravenous antimicrobials for possible bacterial meningitis (and acyclovir if encephalitis is suspected) while results are pending; defer emergent neuroimaging and electroencephalogram (EEG) in a neurologically normal infant without focal signs. Differential should prioritize central nervous system (CNS) infection, metabolic derangements, and fever-triggered onset of an epilepsy syndrome.\n\nC. Obtain emergent Magnetic Resonance Imaging (MRI) of the brain and a routine EEG in all infants after any fever-associated seizure; do not perform LP unless focal neurologic signs are present or the seizure lasts more than $15$ minutes.\n\nD. Label this as a complex febrile seizure because of age less than $6$ months; begin chronic daily antiseizure medication and arrange outpatient neurology follow-up; no infectious workup is necessary unless further seizures occur.\n\nE. Obtain an immediate head Computed Tomography (CT) scan before any LP in all postictal infants to avoid herniation; withhold antimicrobials until CSF results are available; antipyretics alone are sufficient unless a second seizure occurs within $24$ hours.",
            "solution": "The problem statement is subjected to validation before proceeding with a solution.\n\n### Step 1: Extract Givens\n- **Patient Age:** $4$ months\n- **Presenting Complaint:** A single episode of a generalized seizure (tonic stiffening followed by rhythmic jerking) lasting approximately $3$ minutes, which self-terminated.\n- **Associated History:** Fever for $8$ hours, with a maximum recorded temperature of $39.1\\,^{\\circ}\\mathrm{C}$. No prior seizures. No known sick contacts with central nervous system (CNS) infections. No recent antibiotic use.\n- **Immunization Status:** Up to date for age, including two doses of the *Haemophilus influenzae* type b (Hib) vaccine, which does not constitute a completed primary series.\n- **Clinical Course:** Post-ictally, the infant was somnolent for approximately $10$ minutes before returning to a baseline interactive and feeding state.\n- **Physical Examination:**\n    - **Vital Signs:** Temperature $38.7\\,^{\\circ}\\mathrm{C}$, heart rate $160$ beats per minute, respiratory rate $36$ breaths per minute, blood pressure $82/48\\,\\mathrm{mmHg}$.\n    - **Neurological and General Exam:** Soft, non-bulging anterior fontanelle, no nuchal rigidity, normal tone and strength, symmetric reflexes, no focal neurologic deficits. No signs of trauma or rash.\n\n### Step 2: Validate Using Extracted Givens\nThe problem presents a detailed and self-consistent clinical scenario of a first-time seizure in a febrile infant.\n- **Scientifically Grounded:** The entire description is medically and physiologically sound. The clinical presentation, vital signs, and physical examination findings are realistic for a $4$-month-old infant with a fever and recent seizure. The mention of the incomplete Hib immunization series is a clinically relevant and factually correct detail for this age.\n- **Well-Posed:** The problem is well-posed, asking for the most appropriate evaluation and management strategy based on the provided data. Standardized clinical guidelines and principles of pediatric emergency medicine provide a framework for a unique, evidence-based solution.\n- **Objective:** The language is objective and clinical, presenting facts without subjective bias.\n- **Conclusion:** The problem statement is valid. It is a scientifically accurate, complete, and unbiased clinical case that permits a rigorous, principle-based analysis.\n\n### Derivation of the Correct Management Strategy\n\nThe core task is to determine the appropriate management for a $4$-month-old infant presenting with a first-time, fever-associated seizure.\n\n1.  **Analysis of the Seizure Event:** The seizure itself has features of a **simple febrile seizure (SFS)**: it was generalized, lasted less than $15$ minutes (approx. $3$ minutes), and was a single event within a $24$-hour period.\n\n2.  **Crucial Role of Patient Age:** The defining feature of this case is the patient's age of $4$ months. The diagnosis of SFS is typically reserved for children between $6$ months and $5$ years of age. A first-time febrile seizure in an infant under $6$ months of age is considered a high-risk presentation and is not classified as a classic SFS. This is due to two primary reasons:\n    *   **Increased Risk of Serious Bacterial Infection (SBI):** Infants under $6$ months have an immature immune system and are incompletely immunized against major causes of bacterial meningitis, such as *Streptococcus pneumoniae* and *Haemophilus influenzae* type b. The problem explicitly notes the Hib series is incomplete. The incidence of bacterial meningitis presenting as a febrile seizure is significantly higher in this young age group compared to older children.\n    *   **Unreliability of Physical Examination:** Classic signs of meningeal irritation (e.g., nuchal rigidity, Kernig's sign, Brudzinski's sign) are often absent in infants, particularly those younger than $12$ months. A \"well-appearing\" infant with a non-focal neurological exam and a soft fontanelle can still have bacterial meningitis. Therefore, the reassuring physical exam in this case does not sufficiently lower the suspicion for a CNS infection.\n\n3.  **Required Diagnostic Workup:** Based on the high pre-test probability of SBI, particularly meningitis, a comprehensive and urgent workup is mandated.\n    *   **Lumbar Puncture (LP):** An LP for cerebrospinal fluid (CSF) analysis (cell count, differential, protein, glucose, Gram stain, and bacterial culture) is the definitive test to rule out bacterial meningitis and is strongly indicated. Given the possibility of viral encephalitis, sending CSF for Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) is also a reasonable consideration.\n    *   **Sepsis Evaluation:** A full sepsis workup should be performed. This includes a complete blood count (CBC), blood culture, and serum chemistries (including glucose and electrolytes like sodium and calcium to rule out metabolic causes of seizure).\n    *   **Urinary Tract Infection (UTI) Evaluation:** A urinalysis and urine culture are essential, as a UTI is a common source of fever in infants and can lead to bacteremia.\n    *   **Neuroimaging and EEG:** Emergent neuroimaging (CT or MRI) is not indicated in a neurologically stable infant with a non-focal exam and an open fontanelle, as the risk of herniation from an LP is negligible and these tests are low-yield for acute management in this context. Similarly, an electroencephalogram (EEG) is not an emergency procedure; its role is in the subsequent evaluation for an underlying epilepsy syndrome if indicated, not in the acute management of a potential CNS infection.\n\n4.  **Therapeutic Intervention:** Due to the life-threatening nature of bacterial meningitis and the delay in obtaining culture results, empiric intravenous (IV) antimicrobials must be initiated immediately after the LP and other cultures are obtained. A typical regimen would cover the most likely bacterial pathogens for this age group.\n\n### Evaluation of a priori Options\n\n**A. Reassure and discharge after observation; diagnose a simple febrile seizure because the convulsion was generalized, lasted less than $15$ minutes, and occurred once in $24$ hours. No laboratory tests, no lumbar puncture (LP), and no antimicrobials are needed.**\nThis option incorrectly applies the management for a classic simple febrile seizure to an infant who is too young for this diagnosis to be made safely. Discharging a $4$-month-old with a first febrile seizure without a thorough workup to exclude meningitis would be a significant deviation from the standard of care and pose an unacceptable risk to the patient.\n**Verdict: Incorrect.**\n\n**B. Recognize that age less than $6$ months excludes a classic simple febrile seizure diagnosis; perform urgent LP with cerebrospinal fluid (CSF) cell count, glucose, protein, Gram stain, and culture, and add Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) if encephalitis is a concern; obtain serum glucose, sodium, and calcium, a complete blood count and blood culture, urinalysis and urine culture; initiate empiric intravenous antimicrobials for possible bacterial meningitis (and acyclovir if encephalitis is suspected) while results are pending; defer emergent neuroimaging and electroencephalogram (EEG) in a neurologically normal infant without focal signs. Differential should prioritize central nervous system (CNS) infection, metabolic derangements, and fever-triggered onset of an epilepsy syndrome.**\nThis option provides a complete and accurate management plan. It correctly identifies the age criterion as the reason SFS cannot be diagnosed. It mandates the necessary urgent investigations (LP, full sepsis workup), the prompt initiation of empiric therapy, and the appropriate deferral of non-emergent tests like neuroimaging and EEG. The differential diagnosis is also accurate. This approach aligns perfectly with established principles of pediatric emergency medicine.\n**Verdict: Correct.**\n\n**C. Obtain emergent Magnetic Resonance Imaging (MRI) of the brain and a routine EEG in all infants after any fever-associated seizure; do not perform LP unless focal neurologic signs are present or the seizure lasts more than $15$ minutes.**\nThis option prioritizes the wrong investigations and establishes dangerous criteria for performing an LP. Emergent neuroimaging and EEG are not indicated. Critically, it advises against an LP in this high-risk infant, waiting for focal signs or a prolonged seizure, despite the known unreliability of such signs for diagnosing meningitis in this age group. This would lead to a missed or delayed diagnosis of a life-threatening infection.\n**Verdict: Incorrect.**\n\n**D. Label this as a complex febrile seizure because of age less than $6$ months; begin chronic daily antiseizure medication and arrange outpatient neurology follow-up; no infectious workup is necessary unless further seizures occur.**\nThis option contains multiple errors. The event does not meet the definition of a complex febrile seizure (which is based on seizure characteristics, not age). Initiating chronic antiseizure medication for a single seizure is not indicated. Most importantly, it dangerously advises against an infectious workup, which is the most critical step in this patient's management.\n**Verdict: Incorrect.**\n\n**E. Obtain an immediate head Computed Tomography (CT) scan before any LP in all postictal infants to avoid herniation; withhold antimicrobials until CSF results are available; antipyretics alone are sufficient unless a second seizure occurs within $24$ hours.**\nThis option promotes unsafe practices. An immediate head CT is not necessary in an infant with an open fontanelle and non-focal exam. Withholding antimicrobials pending CSF results introduces a critical and potentially fatal delay in treating bacterial meningitis. Relying on antipyretics alone is insufficient and misses the opportunity to treat the potential underlying infection.\n**Verdict: Incorrect.**",
            "answer": "$$\\boxed{B}$$"
        },
        {
            "introduction": "Effective and rapid termination of a seizure is paramount to preventing morbidity. In clinical practice, intravenous access is not always immediately available, necessitating proficiency with alternative administration routes. This exercise  simulates a common emergency scenario, requiring you to weigh the practical advantages and disadvantages of different mucosal benzodiazepine formulations and accurately calculate the appropriate mass-based dose.",
            "id": "5143530",
            "problem": "A $20\\ \\mathrm{kg}$, $18$-month-old child presents with an ongoing generalized tonic-clonic convulsion in the setting of acute febrile illness that began $4$ minutes prior to arrival. There is no prior neurologic disease and no focal features reported. The child has copious oral secretions and lacks Intravenous (IV) access. You must select a non-IV benzodiazepine route to terminate the seizure and compute the absolute dose for both candidate routes to verify safety and feasibility.\n\nUse the following foundational base:\n\n- Definition of febrile seizure: a seizure occurring in association with fever in the absence of central nervous system infection, prior afebrile seizures, or acute metabolic derangement; simple febrile seizures are generalized, last less than $15$ minutes, and do not recur within $24$ hours, while complex febrile seizures are characterized by any of: focal onset or features, duration greater than $15$ minutes, or recurrence within $24$ hours.\n- Rescue therapy for an actively seizing child without IV access can employ mucosal benzodiazepine routes with established mass-based dosing; the absolute drug dose, $D$, follows the mass-based dosing principle $D=\\alpha \\times m$, where $\\alpha$ is the per-kilogram dose and $m$ is the patient mass.\n- Non-IV routes differ in practicality and absorption: intranasal administration leverages the highly vascular nasal mucosa and avoids interference by oral secretions, while buccal administration relies on drug contact with the oral mucosa and may be compromised by copious secretions in an actively seizing child.\n\nTwo candidate regimens are available:\n- Intranasal midazolam at $0.2\\ \\mathrm{mg/kg}$.\n- Buccal midazolam at $0.3\\ \\mathrm{mg/kg}$.\n\nTasks:\n1. Using first-principles reasoning from the above base, decide which route is more appropriate for this specific scenario at minute $4$ of the seizure without IV access and with copious oral secretions. Represent your chosen route as a numeric indicator: $1$ for intranasal, $0$ for buccal.\n2. Compute the absolute dose for each route using $D=\\alpha \\times m$.\n3. Round both doses to two significant figures and express them in $\\mathrm{mg}$.\n\nReport your final answer as a row matrix containing three entries in the following order: chosen route indicator, intranasal dose in $\\mathrm{mg}$, buccal dose in $\\mathrm{mg}$. Round the doses to two significant figures as specified. Do not include units inside the matrix.",
            "solution": "The problem is first subjected to validation.\n\n### Step 1: Extract Givens\n- Patient mass: $m = 20\\ \\mathrm{kg}$\n- Patient age: $18$-month-old\n- Clinical presentation: ongoing generalized tonic-clonic convulsion\n- Duration of seizure prior to arrival: $4$ minutes\n- Pertinent history: no prior neurologic disease, no focal features reported\n- Associated findings: acute febrile illness, copious oral secretions, lacks Intravenous (IV) access\n- Definition of febrile seizure: provided, distinguishing between simple ($< 15$ minutes, generalized, non-recurrent) and complex ($> 15$ minutes, focal, or recurrent).\n- Rescue therapy principle: use mucosal benzodiazepine routes for actively seizing child without IV access.\n- Dosing formula: $D = \\alpha \\times m$, where $D$ is absolute dose, $\\alpha$ is per-kilogram dose, $m$ is patient mass.\n- Information on non-IV routes:\n    - Intranasal: \"avoids interference by oral secretions.\"\n    - Buccal: \"may be compromised by copious secretions in an actively seizing child.\"\n- Candidate regimens:\n    - Intranasal midazolam: $\\alpha_{IN} = 0.2\\ \\mathrm{mg/kg}$.\n    - Buccal midazolam: $\\alpha_{B} = 0.3\\ \\mathrm{mg/kg}$.\n- Tasks:\n    1. Choose the more appropriate route (indicator: $1$ for intranasal, $0$ for buccal).\n    2. Compute the absolute dose for each route.\n    3. Round doses to two significant figures.\n    4. Report as a row matrix: [route indicator, intranasal dose, buccal dose].\n\n### Step 2: Validate Using Extracted Givens\nThe problem is evaluated for validity.\n- **Scientifically Grounded:** The problem is grounded in established principles of pediatric emergency medicine and pharmacology. The clinical scenario, definitions of febrile seizure types, dosing regimens for midazolam, and considerations for administration routes are all standard and factually correct.\n- **Well-Posed:** The problem provides all necessary information (mass, dosing constants, clinical context) to uniquely determine the choice of route based on the provided logic and to calculate the doses. The tasks are specific and unambiguous.\n- **Objective:** The problem statement is presented using precise, unbiased clinical language. It is free of subjective claims.\n\n### Step 3: Verdict and Action\nThe problem is deemed **valid**. It is self-contained, scientifically sound, well-posed, and objective. A solution will be generated.\n\n### Solution Derivation\nThe solution is developed in three parts as specified by the tasks.\n\n**Part 1: Selection of Administration Route**\nThe primary goal is to terminate the seizure effectively and promptly. The choice between the intranasal (IN) and buccal routes depends on which is more reliable in the given clinical context. The problem states the child has \"copious oral secretions.\" The provided foundational base explicitly notes that buccal administration \"may be compromised by copious secretions,\" as the drug's contact with the oral mucosa is essential for absorption. Excessive secretions can dilute the medication, cause it to be swallowed rather than absorbed buccally, and lead to unpredictable and likely sub-therapeutic drug levels. In contrast, the base states that intranasal administration \"avoids interference by oral secretions.\" By delivering the drug to the nasal mucosa, this route bypasses the oral cavity entirely, ensuring that the copious secretions do not hinder drug absorption. Therefore, based on first-principles reasoning from the provided information, the intranasal route is the more appropriate and reliable choice for this patient. The numeric indicator for the chosen route, intranasal, is $1$.\n\n**Part 2: Calculation of Absolute Doses**\nThe absolute dose, $D$, for each route is calculated using the provided formula $D = \\alpha \\times m$.\n\nThe given parameters are:\n- Patient mass, $m = 20\\ \\mathrm{kg}$.\n- Per-kilogram dose for intranasal midazolam, $\\alpha_{IN} = 0.2\\ \\mathrm{mg/kg}$.\n- Per-kilogram dose for buccal midazolam, $\\alpha_{B} = 0.3\\ \\mathrm{mg/kg}$.\n\nFirst, we compute the absolute dose for the intranasal route, $D_{IN}$:\n$$D_{IN} = \\alpha_{IN} \\times m$$\n$$D_{IN} = (0.2\\ \\mathrm{mg/kg}) \\times (20\\ \\mathrm{kg}) = 4\\ \\mathrm{mg}$$\n\nNext, we compute the absolute dose for the buccal route, $D_{B}$:\n$$D_{B} = \\alpha_{B} \\times m$$\n$$D_{B} = (0.3\\ \\mathrm{mg/kg}) \\times (20\\ \\mathrm{kg}) = 6\\ \\mathrm{mg}$$\n\n**Part 3: Rounding and Final Assembly**\nThe final step is to round both calculated doses to two significant figures and assemble the results into the specified matrix format.\n\n- The calculated intranasal dose is $D_{IN} = 4\\ \\mathrm{mg}$. To express this with two significant figures, we write it as $4.0\\ \\mathrm{mg}$.\n- The calculated buccal dose is $D_{B} = 6\\ \\mathrm{mg}$. To express this with two significant figures, we write it as $6.0\\ \\mathrm{mg}$.\n\nThe final answer is a row matrix containing the chosen route indicator, the rounded intranasal dose, and the rounded buccal dose, in that order.\nThe components of the matrix are:\n- Route indicator: $1$\n- Intranasal dose: $4.0$\n- Buccal dose: $6.0$\n\nThe final matrix is $\\begin{pmatrix} 1 & 4.0 & 6.0 \\end{pmatrix}$.",
            "answer": "$$\n\\boxed{\n\\begin{pmatrix} 1 & 4.0 & 6.0 \\end{pmatrix}\n}\n$$"
        },
        {
            "introduction": "Once intravenous access is secured, clinicians can employ first-line IV therapies guided by well-established protocols for managing status epilepticus. Adherence to these protocols, which includes precise weight-based dosing, maximum dose caps, and defined redosing intervals, is critical for both efficacy and patient safety. This practice problem  focuses on the formal application of such a dosing regimen, tasking you with calculating the cumulative dose of lorazepam for a child with a persistent convulsion.",
            "id": "5143555",
            "problem": "A previously healthy child aged $18$ months presents with a generalized tonic–clonic convulsion in the setting of a rectal temperature of $39.2\\,^{\\circ}\\mathrm{C}$. There is no focality on examination, and the seizure has a witnessed duration of $6$ minutes on arrival. Because ongoing convulsions beyond $5$ minutes carry risk of morbidity, benzodiazepine rescue therapy is indicated. Intravenous (IV) lorazepam is selected as first-line therapy.\n\nUse the following well-tested facts as the foundational base:\n- Weight-based dosing is defined as the product of body weight and a standardized dose-per-kilogram, subject to a hard maximum per single dose.\n- For pediatric convulsive seizures in the emergency setting, IV lorazepam is administered at $0.1\\,\\mathrm{mg/kg}$ with a maximum single dose of $4\\,\\mathrm{mg}$, and a second identical dose may be administered once if the seizure persists $5$ minutes after the first dose.\n\nAssume the child weighs $13\\,\\mathrm{kg}$ and the convulsion persists $5$ minutes after the first dose. Starting from the definition of weight-based dosing and the maximum single-dose constraint, compute the cumulative lorazepam amount (in milligrams) that would be administered by $t=10$ minutes if both doses are indicated and given according to these rules. Express your final answer in milligrams and round to three significant figures. Do not include units in your final boxed answer.",
            "solution": "The problem requires the calculation of the cumulative dose of intravenous (IV) lorazepam administered to a child experiencing a prolonged febrile seizure. The calculation must adhere to the provided principles of weight-based dosing and a maximum single-dose constraint.\n\nThe foundational principle of dosing is stated as: \"Weight-based dosing is defined as the product of body weight and a standardized dose-per-kilogram, subject to a hard maximum per single dose.\" We can formalize this relationship mathematically.\n\nLet $W$ represent the child's body weight.\nLet $D_{std}$ be the standardized dose per kilogram of body weight.\nLet $D_{max}$ be the maximum allowable amount for a single dose.\nThe calculated dose, $D_{calc}$, based purely on weight is the product of the weight and the standardized dose:\n$$D_{calc} = W \\times D_{std}$$\nThe actual administered dose for a single administration, $D_{admin}$, must not exceed the maximum single dose, $D_{max}$. Therefore, the administered dose is the lesser of the calculated dose and the maximum dose:\n$$D_{admin} = \\min(D_{calc}, D_{max}) = \\min(W \\times D_{std}, D_{max})$$\n\nFrom the problem statement, we are given the following values:\n- Child's weight, $W = 13\\,\\mathrm{kg}$\n- Standardized IV lorazepam dose, $D_{std} = 0.1\\,\\mathrm{mg/kg}$\n- Maximum single dose, $D_{max} = 4\\,\\mathrm{mg}$\n\nFirst, we calculate the amount for the first dose. The calculated dose, which we will denote $D_{calc,1}$, is:\n$$D_{calc,1} = W \\times D_{std} = 13\\,\\mathrm{kg} \\times 0.1\\,\\frac{\\mathrm{mg}}{\\mathrm{kg}} = 1.3\\,\\mathrm{mg}$$\nNext, we apply the maximum single-dose constraint to determine the administered first dose, $D_{admin,1}$:\n$$D_{admin,1} = \\min(D_{calc,1}, D_{max}) = \\min(1.3\\,\\mathrm{mg}, 4\\,\\mathrm{mg})$$\nSince $1.3\\,\\mathrm{mg}$ is less than $4\\,\\mathrm{mg}$, the first administered dose is:\n$$D_{admin,1} = 1.3\\,\\mathrm{mg}$$\n\nThe problem states that \"the convulsion persists $5$ minutes after the first dose,\" which qualifies the child for a second dose according to the protocol. The protocol allows for \"a second identical dose.\" This implies that the calculation for the second dose follows the same rules and constraints.\nThe calculated second dose, $D_{calc,2}$, is identical to the first:\n$$D_{calc,2} = W \\times D_{std} = 1.3\\,\\mathrm{mg}$$\nThe administered second dose, $D_{admin,2}$, is also subject to the maximum dose constraint:\n$$D_{admin,2} = \\min(D_{calc,2}, D_{max}) = \\min(1.3\\,\\mathrm{mg}, 4\\,\\mathrm{mg})$$\nTherefore, the second administered dose is:\n$$D_{admin,2} = 1.3\\,\\mathrm{mg}$$\n\nThe problem asks for the cumulative lorazepam amount administered by $t=10$ minutes, which encompasses both doses (the first at $t=0$ and the second at $t=5$ minutes). The total cumulative dose, $D_{total}$, is the sum of the two administered doses:\n$$D_{total} = D_{admin,1} + D_{admin,2}$$\nSubstituting the calculated values for each administered dose:\n$$D_{total} = 1.3\\,\\mathrm{mg} + 1.3\\,\\mathrm{mg} = 2.6\\,\\mathrm{mg}$$\n\nFinally, the problem requires the answer to be expressed in milligrams and rounded to three significant figures. The calculated value is $2.6$. To express this with three significant figures, we add a trailing zero:\n$$D_{total} = 2.60\\,\\mathrm{mg}$$",
            "answer": "$$\n\\boxed{2.60}\n$$"
        }
    ]
}